Seeking three startups to participate in an ILP webinar on Advances in Cell Therapy and Regenerative Medicine on September 23, 2020.
Takeda is looking for new approaches and technologies that can help them address challenges/opportunities in gastroenterology, oncology, neuroscience and rare genetic & hematology.
Looking for 8-10 startups to present their tech on April 12 at the 2022 MIT Health Science Technologies Conference: The Future of Cell & Gene Therapies.
Lightning Talk and Exhibitor Opportunity, Organized by MIT Media Lab with contributions from MIT Startup Exchange and Takeda Pharmaceuticals
Elbit America, a fast-growing defense company, is seeking technology partnership with startups in digital transformation, sonar / acoustics, HSA/DM, sensors, augmented reality, artificial intelligence / machine learning, optics, non GPS dependent precision north finding & non GPS dependent precision navigation and timing, precision Line of Sight (LOS) sensing, optical communications, and advanced video and image processing.
MIT Startup Exchange will select 4 startups to present and exhibit at the 2025 MIT Health & Science Forum on May 8.
Bringing the Power of Medicinal Chemistry to Protein Therapies
A leading pharmaceutical company in Amyotrophic Lateral Sclerosis (ALS) is interested in speaking with startups whose technology could contribute to very early diagnosis of the disease.